References
- Allegra, A., Alonci, A., Campo, S., Penna, G., Petrungaro, A., Gerace, D., and Musolino, C. (2012). Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review). Int. J. Oncol. 41, 1897-1912. https://doi.org/10.3892/ijo.2012.1647
- Bartel, D.P. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233. https://doi.org/10.1016/j.cell.2009.01.002
- Catto, J.W., Alcaraz, A., Bjartell, A.S., De Vere White, R., Evans, C.P., Fussel, S., Hamdy, F.C., Kallioniemi, O., Mengual, L., Schlomm, T., et al. (2011). MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur. Urol. 59, 671-681. https://doi.org/10.1016/j.eururo.2011.01.044
- Chen, J., Feilotter, H.E., Pare, G.C., Zhang, X., Pemberton, J.G., Garady, C., Lai, D., Yang, X., and Tron, V.A. (2010). MicroRNA- 193b represses cell proliferation and regulates cyclin D1 in melanoma. Am. J. Pathol. 176, 2520-2529. https://doi.org/10.2353/ajpath.2010.091061
- Cho, W.C. (2010). MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell Biol. 42, 1273-1281. https://doi.org/10.1016/j.biocel.2009.12.014
- Coskun, E., Neumann, M., Schlee, C., Liebertz, F., Heesch, S., Goekbuget, N., Hoelzer, D., and Baldus, C.D. (2013). MicroRNA profiling reveals aberrant microRNA expression in adult ETPALL and functional studies implicate a role for miR-222 in acute leukemia. Leuk. Res. 37, 647-656. https://doi.org/10.1016/j.leukres.2013.02.019
- Fang, Y., Cao, Z., Hou, Q., Ma, C., Yao, C., Li, J., Wu, X.R., and Huang, C. (2013). Cyclin d1 downregulation contributes to anticancer effect of isorhapontigenin on human bladder cancer cells. Mol. Cancer Ther. 12, 1492-1503. https://doi.org/10.1158/1535-7163.MCT-12-0922
- Fendler, A., Stephan, C., Yousef, G.M., and Jung, K. (2011). MicroRNAs as regulators of signal transduction in urological tumors. Clin. Chem. 57, 954-968. https://doi.org/10.1373/clinchem.2010.157727
- Friedman, R.C., Farh, K.K., Burge, C.B., and Bartel, D.P. (2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105.
- Fu, M., Wang, C., Li, Z., Sakamaki, T., and Pestell, R.G. (2004). Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 145, 5439-5447. https://doi.org/10.1210/en.2004-0959
- Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., and Forman, D. (2011). Global cancer statistics. CA Cancer J. Clin. 61, 69-90. https://doi.org/10.3322/caac.20107
- Kim, J.K., and Diehl, J.A. (2009). Nuclear cyclin D1: an oncogenic driver in human cancer. J. Cell. Physiol. 220, 292-296. https://doi.org/10.1002/jcp.21791
- Kopparapu, P.K., Boorjian, S.A., Robinson, B.D., Downes, M., Gudas, L.J., Mongan, N.P., and Persson, J.L. (2013). Expression of cyclin d1 and its association with disease characteristics in bladder cancer. Anticancer Res. 33, 5235-5242.
- Li, S., Xu, X., Xu, X., Hu, Z., Wu, J., Zhu, Y., Chen, H., Mao, Y., Lin, Y., Luo, J., et al. (2013). MicroRNA-490-5p inhibits proliferation of bladder cancer by targeting c-Fos. Biochem. Biophys. Res. Commun. 441, 976-981. https://doi.org/10.1016/j.bbrc.2013.11.006
- Lin, T., Dong, W., Huang, J., Pan, Q., Fan, X., Zhang, C., and Huang, L. (2009). MicroRNA-143 as a tumor suppressor for bladder cancer. J. Urol. 181, 1372-1380. https://doi.org/10.1016/j.juro.2008.10.149
- Lin, Y., Wu, J., Chen, H., Mao, Y., Liu, Y., Mao, Q., Yang, K., Zheng, X., and Xie, L. (2012). Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells. FEBS Lett. 586, 442-447. https://doi.org/10.1016/j.febslet.2012.01.027
- Lin, Y., Chen, H., Hu, Z., Mao, Y., Xu, X., Zhu, Y., Xu, X., Wu, J., Li, S., Mao, Q., et al. (2013). miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1. FEBS Lett. 587, 2467-2473. https://doi.org/10.1016/j.febslet.2013.06.021
- Liu, J.Y., Qian, D., He, L.R., Li, Y.H., Liao, Y.J., Mai, S.J., Tian, X.P., Liu, Y.H., Zhang, J.X., Kung, H.F., et al. (2013). PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway. Mol. Cancer 12, 148. https://doi.org/10.1186/1476-4598-12-148
- Majid, S., Dar, A.A., Saini, S., Deng, G., Chang, I., Greene, K., Tanaka, Y., Dahiya, R., and Yamamura, S. (2013). MicroRNA- 23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. PLoS One 8, e67686. https://doi.org/10.1371/journal.pone.0067686
- Malumbres, M., and Barbacid, M. (2009). Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 9, 153-166. https://doi.org/10.1038/nrc2602
- Nana-Sinkam, S.P., and Croce, C.M. (2010). MicroRNA dysregulation in cancer: opportunities for the development of microRNA-based drugs. Invest. Drugs J. 13, 843-846.
- Osaki, M., Takeshita, F., and Ochiya, T. (2008). MicroRNAs as biomarkers and therapeutic drugs in human cancer. Biomarkers 13, 658-670. https://doi.org/10.1080/13547500802646572
- Piva, R., Spandidos, D.A., and Gambari, R. (2013). From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review). Int. J. Oncol. 43, 985-994. https://doi.org/10.3892/ijo.2013.2059
- Place, R.F., Li, L.C., Pookot, D., Noonan, E.J., and Dahiya, R. (2008). MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl. Acad. Sci. USA 105, 1608-1613. https://doi.org/10.1073/pnas.0707594105
- Ploeg, M., Aben, K.K., and Kiemeney, L.A. (2009). The present and future burden of urinary bladder cancer in the world. World J. Urol. 27, 289-293. https://doi.org/10.1007/s00345-009-0383-3
- Ratert, N., Meyer, H.A., Jung, M., Lioudmer, P., Mollenkopf, H.J., Wagner, I., Miller, K., Kilic, E., Erbersdobler, A., Weikert, S., et al. (2013). miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome. J. Mol. Diagn. 15, 695-705. https://doi.org/10.1016/j.jmoldx.2013.05.008
- Satyanarayana, A., and Kaldis, P. (2009). Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 28, 2925-2939. https://doi.org/10.1038/onc.2009.170
- Shi, Z., Wei, Q., Zhang, M., and She, J. (2014). MicroRNAs in bladder cancer: expression profiles, biological functions, regulation, and clinical implications. Crit. Rev. Eukaryot. Gene Expr. 24, 55-75. https://doi.org/10.1615/CritRevEukaryotGeneExpr.2014007798
- Sun, F., Fu, H., Liu, Q., Tie, Y., Zhu, J., Xing, R., Sun, Z., and Zheng, X. (2008). Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett. 582, 1564-1568. https://doi.org/10.1016/j.febslet.2008.03.057
- Tashiro, E., Tsuchiya, A., and Imoto, M. (2007). Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci. 98, 629-635. https://doi.org/10.1111/j.1349-7006.2007.00449.x
- Tatarano, S., Chiyomaru, T., Kawakami, K., Enokida, H., Yoshino, H., Hidaka, H., Yamasaki, T., Kawahara, K., Nishiyama, K., Seki, N., et al. (2011). miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer. Int. J. Oncol. 39, 13-21.
- Witzel, II, Koh, L.F., and Perkins, N.D. (2010). Regulation of cyclin D1 gene expression. Biochem. Soc. Trans. 38, 217-222. https://doi.org/10.1042/BST0380217
- Xia, H., Qi, Y., Ng, S.S., Chen, X., Chen, S., Fang, M., Li, D., Zhao, Y., Ge, R., Li, G., et al. (2009). MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. Biochem. Biophys. Res. Commun. 380, 205-210. https://doi.org/10.1016/j.bbrc.2008.12.169
- Zhang, Z.C., Huang, Y., Wang, X.J., Wang, M., and Ma, L.L. (2013). Expression of circulating microRNAs in patients with bladder urothelial carcinoma. Beijing Da Xue Xue Bao 45, 532-536.
Cited by
- The role of microRNAs in bladder cancer vol.57, pp.Suppl 1, 2016, https://doi.org/10.4111/icu.2016.57.S1.S60
- Down-Regulation of MicroRNA-210 Confers Sensitivity towards 1’S-1’-Acetoxychavicol Acetate (ACA) in Cervical Cancer Cells by Targeting SMAD4 vol.40, pp.4, 2017, https://doi.org/10.14348/molcells.2017.2285
- miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression vol.50, pp.6, 2017, https://doi.org/10.3892/ijo.2017.3969
- MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin vol.579, pp.2, 2016, https://doi.org/10.1016/j.gene.2015.12.048
- MicroRNA-101 inhibits the proliferation and invasion of bladder cancer cells via targeting c-FOS vol.14, pp.3, 2016, https://doi.org/10.3892/mmr.2016.5534
- c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial–mesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling vol.7, pp.2, 2016, https://doi.org/10.1038/cddis.2015.274
- MicroRNA-24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3 vol.47, pp.4, 2015, https://doi.org/10.3892/ijo.2015.3117
- Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer vol.95, pp.10, 2015, https://doi.org/10.1038/labinvest.2015.88
- miR-1182 inhibits growth and mediates the chemosensitivity of bladder cancer by targeting hTERT vol.470, pp.2, 2016, https://doi.org/10.1016/j.bbrc.2016.01.014
- Ellipticine inhibits the proliferation and induces apoptosis in rheumatoid arthritis fibroblast-like synoviocytes via the STAT3 pathway vol.39, pp.4, 2017, https://doi.org/10.1080/08923973.2017.1327963
- MET/SMAD3/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial–mesenchymal transition progression in bladder cancer vol.8, pp.8, 2017, https://doi.org/10.1038/cddis.2017.331
- miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer vol.7, pp.12, 2016, https://doi.org/10.1038/cddis.2016.373
- MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway vol.16, pp.1, 2017, https://doi.org/10.1186/s12943-017-0664-1
- MiR-22 suppresses epithelial–mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop vol.9, pp.2, 2018, https://doi.org/10.1038/s41419-017-0206-1
- MIR-300 in the imprinted DLK1-DIO3 domain suppresses the migration of bladder cancer by regulating the SP1/MMP9 pathway vol.17, pp.24, 2018, https://doi.org/10.1080/15384101.2018.1557490
- Novel non invasive diagnostic strategies in bladder cancer vol.89, pp.2, 2015, https://doi.org/10.15386/cjmed-534
- miRNA expression profiles of premalignant and malignant arsenic-induced skin lesions vol.13, pp.8, 2018, https://doi.org/10.1371/journal.pone.0202579
- MicroRNA-124 inhibits cell proliferation, invasion and migration by targeting CAV1 in bladder cancer vol.16, pp.4, 2015, https://doi.org/10.3892/etm.2018.6537
- Dual regulatory role of CCNA2 in modulating CDK6 and MET‐mediated cell‐cycle pathway and EMT progression is blocked by miR‐381‐3p in bladder cancer vol.33, pp.1, 2015, https://doi.org/10.1096/fj.201800667r
- Targeting of SGK1 by miR-576-3p Inhibits Lung Adenocarcinoma Migration and Invasion vol.17, pp.1, 2015, https://doi.org/10.1158/1541-7786.mcr-18-0364
- CCND1, NOP14 and DNMT3B are involved in miR‐502‐5p–mediated inhibition of cell migration and proliferation in bladder cancer vol.53, pp.2, 2015, https://doi.org/10.1111/cpr.12751
- Clinical Potentials of miR-576-3p, miR-613, NDRG2 and YKL40 in Colorectal Cancer Patients vol.21, pp.6, 2020, https://doi.org/10.31557/apjcp.2020.21.6.1689
- Long noncoding RNA ZFPM2-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the miR-576-3p/HIF-1α axis vol.32, pp.8, 2021, https://doi.org/10.1097/cad.0000000000001070
- Export Control: Post-transcriptional Regulation of the COPII Trafficking Pathway vol.8, pp.None, 2021, https://doi.org/10.3389/fcell.2020.618652